Pentwater Capital Management LP Alx Oncology Holdings Inc Transaction History

Pentwater Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$21.49 - $74.4 $277,178 - $959,611	-12,898 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$52.51 - $80.91 $5,356 - $8,252	-102 Reduced 0.78%	12,898 $953,000
Q2 2021 Aug 16, 2021	BUY	$52.2 - $75.23 $156,600 - $225,690	3,000 Added 30.0%	13,000 $711,000
Q1 2021 May 17, 2021	BUY	$62.84 - $87.68 $125,680 - $175,360	2,000 Added 25.0%	10,000 $737,000
Q4 2020 Feb 16, 2021	SELL	$34.11 - $112.26 $405,909 - $1.34 Million	-11,900 Reduced 59.8%	8,000 $690,000
Q3 2020 Nov 16, 2020	BUY	$29.36 - $47.1 $584,264 - $937,290	19,900 New	19,900 $751,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.